Bye, A. P., Unsworth, A. J., Desborough, M. J., Hildyard, C. A. T., Appleby, N., Bruce, D., . . . Gibbins, J. M. (2017). Severe platelet dysfunction in NHL patients receiving ibrutinib is absent in patients receiving acalabrutinib. Blood Adv.
Čikaški stil citiranjaBye, Alexander P., et al. "Severe Platelet Dysfunction in NHL Patients Receiving Ibrutinib Is Absent in Patients Receiving Acalabrutinib." Blood Adv 2017.
MLA način citiranjaBye, Alexander P., et al. "Severe Platelet Dysfunction in NHL Patients Receiving Ibrutinib Is Absent in Patients Receiving Acalabrutinib." Blood Adv 2017.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.